Affiliation:
1. Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangdong Province, Guangzhou, China
2. National Tuberculosis Reference Laboratory, China Center for Disease Control and Prevention, Beijing, China
Abstract
ABSTRACT
We aimed to study the distribution and contribution of mutations in the
rpoB
whole gene in rifampin-resistant/rifabutin-resistant (RIF
r
/Rfb
r
) (or RIF/Rfb cross-resistant) clinical
Mycobacterium tuberculosis
isolates. One standard
M. tuberculosis
strain (H37Rv) and 392 other clinical
M. tuberculosis
isolates mainly from Guangdong Province of China whose susceptibilities to rifampin (RIF), rifabutin (Rfb), streptomycin (SM), ethambutol (EMB), and isoniazid (INH) were previously determined were subjected to DNA sequencing of their
rpoB
whole genes. H37Rv and the 30 drug-susceptible clinical isolates had no mutations in
rpoB
whole genes. In 43 rifampin-resistant/rifabutin-susceptible (RIF
r
/Rfb
s
) isolates, the most frequent mutation codons were 516 (62.80%), 526 (14.0%), and 533 (6.98%), but codon 531 had no mutation. Twenty-one of the 43 isolates (48.84%) had single mutations of H526L, H526S, D516V, D516Y, and D516F. In 319 RIF
r
/Rfb
r
isolates, the most frequent mutation codons were 531 (73.7%) and 526 (18.8%); the mutation frequency for codon 516 was 2.5%, and that for codon 533 was only 0.31%. A total of 82.8% (264/319) of them had single mutations of S531L, S531W, H526D, H526Y, H526R, Q513K, Q513P, Q510H, V176F, P206
T
R, Y314
T
C, and H323
T
Y (the superscript T indicates
M. tuberculosis
numbering; the remaining codons use the
E. coli
numbering), among which V176F, P206
T
R, Y314
T
C, and H323
T
Y were located in the beginning of
rpoB
, and all of them were present in 1.9% (6/319) of RIF
r
/Rfb
r
isolates. The multiple mutations in RIF
r
/Rfb
r
isolates and in RIF
r
/Rfb
s
isolates were also different from each other either in mutation positions or in types of mutation combinations. In conclusion, the mutations of
rpoB
in RIF-R/Rfb
s
and in RIF-R/Rfb-R isolates differ significantly from each other not only in the most frequent mutation codons (516, 531, and 533) but also in the most frequent single mutations (S531L, H526L, D516V, D516Y, and D516F), and the beginning of
rpoB
may confer a RIF/Rfb cross-resistance phenotype in
M. tuberculosis
. Molecular assays for identifying RIF/Rfb cross-resistance in
M. tuberculosis
might be improved in terms of accuracy by including this region, in addition to the rifampin resistance determination region.
Publisher
American Society for Microbiology
Reference20 articles.
1. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
3. Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in
Mycobacterium tuberculosis
Isolates
4. Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains;Chikamatsu K;Kekkaku,2009
5. Direct rapid diagnosis of rifampicin resistant Mycobacterium tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif. TB);Cirillo DM;New Microbiol.,2004